Similar articles

• High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.

  Nirenberg A, Mosende C, Mehta BM, Gisolfi AL, Rosen G. Nirenberg A, et al. Cancer Treat Rep. 1977 Aug;61(5):779-83. Cancer Treat Rep. 1977. PMID: 302143 Clinical Trial. No abstract available.
• Biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate treatment: implications for therapy.

  Wilmans W, Sauer W, Schalhorn A. Wilmans W, et al. Recent Results Cancer Res. 1978;68:33-9. doi: 10.1007/978-3-642-81332-0_6. Recent Results Cancer Res. 1978. PMID: 313587 No abstract available.
• High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.

  Sirotnak FM, Donsbach RC, Dorick DM, Moccio DM. Sirotnak FM, et al. Cancer Treat Rep. 1977 Jul;61(4):565-74. Cancer Treat Rep. 1977. PMID: 301778 No abstract available.
• Methotrexate. II. Use in pediatric chemotherapy.

  Lippens RJ. Lippens RJ. Am J Pediatr Hematol Oncol. 1984 Winter;6(4):397-413. Am J Pediatr Hematol Oncol. 1984. PMID: 6398630 Review.
• Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor.

  Bender RA. Bender RA. Cancer Treat Rev. 1975 Sep;2(3):215-24. doi: 10.1016/s0305-7372(75)80004-1. Cancer Treat Rev. 1975. PMID: 1104164 Review. No abstract available.